SONO TEK CORP (SOTK) Form 10-Q — Oct 14, 2026
Sono-Tek reported first-half fiscal 2027 net sales of $10.9 million, up 6% year over year, driven by medical-sector sales that surged 289% to $7.1 million on stent-coating and drug-coated balloon systems. First-half operating income rose 41% to $1.28 million with gross margin expanding 400 basis points to 55%, though Q2 net income of $366,000 declined from $424,000 a year ago as operating expenses grew. Backlog of $9.5 million was down $1.7 million year over year but rose 23% sequentially. The company holds $17.7 million in cash and securities with no debt.
Key figures
- Eps
- 0.07
- Revenue
- 10893000
- Net Income
- 1107462
- Revenue Yoy
- 0.06
- Total Assets
- 26399575
- Cash Position
- 17755000
- Shares Outstanding
- 15751736
- Q2 eps
- 0.02
- Backlog
- 9510000
- Q2 revenue
- 5232000
- Total debt
- 0
- Q2 net income
- 366294
- H1 gross margin
- 55%
- Q2 gross margin
- 53%
- Medical sales h1
- 7050000
- H1 operating income
- 1279000
- Post quarter orders
- 7190000
- Medical sales h1 yoy
- 289%
- Clean energy sales h1
- 855000
- Operating cash flow h1
- 3102490
- Backlog sequential change
- 1780000
- Clean energy sales h1 yoy
- -85%
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.